India’s weight loss category is undergoing a dynamic transformation triggered by scientific improvements, pharma innovation, and growing consumer demand ...

Compounded semaglutide helps manage blood sugar and curb appetite for better diabetes control and weight loss. Learn how it ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

Five scientists won this year’s Breakthrough Prize in Life Sciences for their work on GLP-1 and the development of drugs for diabetes and obesity.

and GLP-1 (glucagon-like peptide-1), which regulates blood sugar levels by stimulating insulin secretion and reducing glucagon release. This once-a-week injection has been approved by India’s ...

Although research suggests that flavonoids may promote insulin secretion by inhibiting glucagon secretion in T2DM, thereby preserving GIP levels, these observations have not been confirmed by ...

SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

The addition of a candidate targeting glucagon, as well as GLP-1 and GIP, will add important optionality to our clinical pipeline, as we look to develop a broad portfolio of differentiated treatment ...